On October 26, 2021 Celon Pharma SA reported that it will take part in the 12th edition of the largest European conference on life science (Press release, Celon Pharma, OCT 26, 2021, View Source [SID1234591951]). The conference will be attended by leading companies from the pharmaceutical, biotechnology, medical technology and healthcare services sectors from the Americas, Europe, the Middle East, Africa, Asia and Australia.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

This conference is a must on the map of our investor relations activities, as well as the development of our business. In this edition, we will focus on maintaining relations with our foreign investors who took part in the last issue, as well as hold a series of business meetings concerning both the area of ​​generic and innovative business development – Dr. Maciej Wieczorek, President of the Management Board of Celon Pharma SA The representatives of the Company will be available in virtual one-to-one sessions, for interested parties on November 18 and 19, 2021. To register, please contact a Jefferies representative: [email protected]